English

SCOLR Pharma, Inc.

EDGAR

Quarterly report (10-Q) · filed 2011-11-10

61 filing records in this dataset, filed from 1998-11-13 to 2011-11-10. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

12 thousand Unit1

2011 Q3 · Unit1

Exact inputs and evidence

Revenue: 12000 Unit1 Source

Operating margin

-5,025%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -603000 Unit1 Source
Revenue: 12000 Unit1 Source

Operating cash flow

-557 thousand Unit1

2011 Q3 · Unit1

Exact inputs and evidence

Operating Cash Flow: -2872000 Unit1 Source
Operating Cash Flow: -2315000 Unit1 Source

Cash and cash equivalents: 645 thousand Unit1 2011-09-30 Source
Exact value

645000 Unit1
Long-term debt including current maturities: Not available
Shares outstanding: 49.8 million Unit12 2011-09-30 Source
Exact value

49816073 Unit12

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-11-10.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2010-12-31
Operating income: 10 of 11 periods available· newest 2010-12-31
Net income: 10 of 11 periods available· newest 2010-12-31
Operating cash flow: 6 of 11 periods available· newest 2010-12-31
capital expenditure: No compatible figures in this window
Total assets: 1 of 11 periods available· newest 2010-12-31
Total liabilities: 1 of 11 periods available· newest 2010-12-31
Current assets: 1 of 11 periods available· newest 2010-12-31
Current liabilities: 1 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
Shares outstanding: 1 of 11 periods available· newest 2010-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-33.9%

Prior period

USD 935,000

2009-01-01 – 2009-12-31
Current period

USD 618,000

2010-01-01 – 2010-12-31

Exact inputs and evidence

618000 − 935000 = -317000 USD

935000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
618000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SCOLR Pharma, Inc. · 2010-12-31 SCOLR Pharma, Inc. (edgar:934936) Year-over-year change in Revenue: -317000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 618000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#4622 Input fundies:Revenue: 935000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#4622
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 3.66 million

Prior period

−USD 6.87 million

2009-01-01 – 2009-12-31
Current period

−USD 3.21 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-3205000 − -6869000 = 3664000 USD

-6869000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-3205000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SCOLR Pharma, Inc. · 2010-12-31 SCOLR Pharma, Inc. (edgar:934936) Year-over-year change in Net income: 3664000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3205000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5378 Input fundies:NetIncome: -6869000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5378
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.05 million

Prior period

−USD 5 million

2009-01-01 – 2009-12-31
Current period

−USD 2.96 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-2957000 − -5002000 = 2045000 USD

-5002000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-2957000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SCOLR Pharma, Inc. · 2010-12-31 SCOLR Pharma, Inc. (edgar:934936) Year-over-year change in Operating cash flow: 2045000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -2957000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5538 Input fundies:OperatingCashFlow: -5002000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5538
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 618,000 100% of revenue
Operating costs Derived USD 4.08 million 661% of revenue
Operating income −USD 3.46 million −561% of revenue
Tax, interest and other Derived −USD 259,000 −42% of revenue
Net income −USD 3.21 million −519% of revenue

Cash

Operating cash flow −USD 2.96 million −478% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 115% of revenue.
2002 Operating loss: operating costs were 135% of revenue.
2003 Operating loss: operating costs were 146% of revenue.
2004 Operating loss: operating costs were 1,247% of revenue.
2005 Operating loss: operating costs were 1,484% of revenue.
2006 Operating loss: operating costs were 647% of revenue.
2007 Operating loss: operating costs were 672% of revenue.
2008 Operating loss: operating costs were 763% of revenue.
2009 Operating loss: operating costs were 817% of revenue.
2010 Operating loss: operating costs were 661% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	8190500	9396236 Derived	-1205736	-632694 Derived	-573042	Unavailable	Source 2001-01-01 – 2001-12-31: 8190500 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -1205736 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -573042 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 685018 USD Inspect Operating Cash Flow Open source
2002 2002-01-01 – 2002-12-31	6514243	8783425 Derived	-2269182	391970 Derived	-2661152	Unavailable	Source 2002-01-01 – 2002-12-31: 6514243 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -2269182 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -2661152 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -960207 USD Inspect Operating Cash Flow Open source
2003 2003-01-01 – 2003-12-31	6594073	9652873 Derived	-3058800	5683737 Derived	-8742537	Unavailable	Source 2003-01-01 – 2003-12-31: 6594073 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -3058800 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -8742537 USD Inspect Net Income Open source
2004 2004-01-01 – 2004-12-31	441993	5512266 Derived	-5070273	677408 Derived	-5747681	Unavailable	Source 2004-01-01 – 2004-12-31: 441993 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -5070273 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -5747681 USD Inspect Net Income Open source
2005 2005-01-01 – 2005-12-31	635407	9432205 Derived	-8796798	89265 Derived	-8886063	Unavailable	Source 2005-01-01 – 2005-12-31: 635407 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -8796798 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -8886063 USD Inspect Net Income Open source
2006 2006-01-01 – 2006-12-31	2278449	14743864 Derived	-12465415	-1722185 Derived	-10743230	Unavailable	Source 2006-01-01 – 2006-12-31: 2278449 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -12465415 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -10743230 USD Inspect Net Income Open source
2007 2007-01-01 – 2007-12-31	1971783	13259948 Derived	-11288165	-669227 Derived	-10618938	Unavailable	Source 2007-01-01 – 2007-12-31: 1971783 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -11288165 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -10618938 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -7758021 USD Inspect Operating Cash Flow Open source
2008 2008-01-01 – 2008-12-31	958000	7314000 Derived	-6356000	-216000 Derived	-6140000	Unavailable	Source 2008-01-01 – 2008-12-31: 958000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -6356000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -6140000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -4727000 USD Inspect Operating Cash Flow Open source
2009 2009-01-01 – 2009-12-31	935000	7642000 Derived	-6707000	162000 Derived	-6869000	Unavailable	Source 2009-01-01 – 2009-12-31: 935000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -6707000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -6869000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -5002000 USD Inspect Operating Cash Flow Open source
2010 2010-01-01 – 2010-12-31	618000	4082000 Derived	-3464000	-259000 Derived	-3205000	Unavailable	Source 2010-01-01 – 2010-12-31: 618000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -3464000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -3205000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -2957000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 618K 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	8190500	Revenue: 8190500 Open source
20022002-12-31	Revenue	6514243	Revenue: 6514243 Open source
20032003-12-31	Revenue	6594073	Revenue: 6594073 Open source
20042004-12-31	Revenue	441993	Revenue: 441993 Open source
20052005-12-31	Revenue	635407	Revenue: 635407 Open source
20062006-12-31	Revenue	2278449	Revenue: 2278449 Open source
20072007-12-31	Revenue	1971783	Revenue: 1971783 Open source
20082008-12-31	Revenue	958000	Revenue: 958000 Open source
20092009-12-31	Revenue	935000	Revenue: 935000 Open source
20102010-12-31	Revenue	618000	Revenue: 618000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-33.9% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 8190500 Open source
20022002-12-31	Year over year	-20.5%	Revenue: 6514243 Open source Revenue: 8190500 Open source
20032003-12-31	Year over year	1.2%	Revenue: 6594073 Open source Revenue: 6514243 Open source
20042004-12-31	Year over year	-93.3%	Revenue: 441993 Open source Revenue: 6594073 Open source
20052005-12-31	Year over year	43.8%	Revenue: 635407 Open source Revenue: 441993 Open source
20062006-12-31	Year over year	258.6%	Revenue: 2278449 Open source Revenue: 635407 Open source
20072007-12-31	Year over year	-13.5%	Revenue: 1971783 Open source Revenue: 2278449 Open source
20082008-12-31	Year over year	-51.4%	Revenue: 958000 Open source Revenue: 1971783 Open source
20092009-12-31	Year over year	-2.4%	Revenue: 935000 Open source Revenue: 958000 Open source
20102010-12-31	Year over year	-33.9%	Revenue: 618000 Open source Revenue: 935000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -560.5% 2010

Net margin -518.6% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	-14.7%	Operating Income: -1205736 Open source Revenue: 8190500 Open source
20022002-12-31	Operating margin	-34.8%	Operating Income: -2269182 Open source Revenue: 6514243 Open source
20032003-12-31	Operating margin	-46.4%	Operating Income: -3058800 Open source Revenue: 6594073 Open source
20042004-12-31	Operating margin	-1,147.1%	Operating Income: -5070273 Open source Revenue: 441993 Open source
20052005-12-31	Operating margin	-1,384.4%	Operating Income: -8796798 Open source Revenue: 635407 Open source
20062006-12-31	Operating margin	-547.1%	Operating Income: -12465415 Open source Revenue: 2278449 Open source
20072007-12-31	Operating margin	-572.5%	Operating Income: -11288165 Open source Revenue: 1971783 Open source
20082008-12-31	Operating margin	-663.5%	Operating Income: -6356000 Open source Revenue: 958000 Open source
20092009-12-31	Operating margin	-717.3%	Operating Income: -6707000 Open source Revenue: 935000 Open source
20102010-12-31	Operating margin	-560.5%	Operating Income: -3464000 Open source Revenue: 618000 Open source
20012001-12-31	Net margin	-7%	Net Income: -573042 Open source Revenue: 8190500 Open source
20022002-12-31	Net margin	-40.9%	Net Income: -2661152 Open source Revenue: 6514243 Open source
20032003-12-31	Net margin	-132.6%	Net Income: -8742537 Open source Revenue: 6594073 Open source
20042004-12-31	Net margin	-1,300.4%	Net Income: -5747681 Open source Revenue: 441993 Open source
20052005-12-31	Net margin	-1,398.5%	Net Income: -8886063 Open source Revenue: 635407 Open source
20062006-12-31	Net margin	-471.5%	Net Income: -10743230 Open source Revenue: 2278449 Open source
20072007-12-31	Net margin	-538.5%	Net Income: -10618938 Open source Revenue: 1971783 Open source
20082008-12-31	Net margin	-640.9%	Net Income: -6140000 Open source Revenue: 958000 Open source
20092009-12-31	Net margin	-734.7%	Net Income: -6869000 Open source Revenue: 935000 Open source
20102010-12-31	Net margin	-518.6%	Net Income: -3205000 Open source Revenue: 618000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 8190500 Open source Operating Cash Flow: 685018 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 6514243 Open source Operating Cash Flow: -960207 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 6594073 Open source
20042004-12-31	Free cash flow margin	Not reported	Revenue: 441993 Open source
20052005-12-31	Free cash flow margin	Not reported	Revenue: 635407 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 2278449 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 1971783 Open source Operating Cash Flow: -7758021 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 958000 Open source Operating Cash Flow: -4727000 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 935000 Open source Operating Cash Flow: -5002000 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 618000 Open source Operating Cash Flow: -2957000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -3M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	685018	Operating Cash Flow: 685018 Open source
20022002-12-31	Operating cash flow	-960207	Operating Cash Flow: -960207 Open source
20032003-12-31	Operating cash flow	Not reported	No source recorded
20042004-12-31	Operating cash flow	Not reported	No source recorded
20052005-12-31	Operating cash flow	Not reported	No source recorded
20062006-12-31	Operating cash flow	Not reported	No source recorded
20072007-12-31	Operating cash flow	-7758021	Operating Cash Flow: -7758021 Open source
20082008-12-31	Operating cash flow	-4727000	Operating Cash Flow: -4727000 Open source
20092009-12-31	Operating cash flow	-5002000	Operating Cash Flow: -5002000 Open source
20102010-12-31	Operating cash flow	-2957000	Operating Cash Flow: -2957000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	Unavailable	Operating Cash Flow: 685018 Open source
20022002-12-31	Free cash flow	Unavailable	Operating Cash Flow: -960207 Open source
20032003-12-31	Free cash flow	Unavailable	No source recorded
20042004-12-31	Free cash flow	Unavailable	No source recorded
20052005-12-31	Free cash flow	Unavailable	No source recorded
20062006-12-31	Free cash flow	Unavailable	No source recorded
20072007-12-31	Free cash flow	Unavailable	Operating Cash Flow: -7758021 Open source
20082008-12-31	Free cash flow	Unavailable	Operating Cash Flow: -4727000 Open source
20092009-12-31	Free cash flow	Unavailable	Operating Cash Flow: -5002000 Open source
20102010-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2957000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	No source recorded
2004-12-31	Liabilities / assets	Not reported	No source recorded
2005-12-31	Liabilities / assets	Not reported	No source recorded
2006-12-31	Liabilities / assets	Not reported	No source recorded
2007-12-31	Liabilities / assets	Not reported	No source recorded
2008-12-31	Liabilities / assets	Not reported	No source recorded
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Current assets / current liabilities	Not reported	No source recorded
2002-12-31	Current assets / current liabilities	Not reported	No source recorded
2003-12-31	Current assets / current liabilities	Not reported	No source recorded
2004-12-31	Current assets / current liabilities	Not reported	No source recorded
2005-12-31	Current assets / current liabilities	Not reported	No source recorded
2006-12-31	Current assets / current liabilities	Not reported	No source recorded
2007-12-31	Current assets / current liabilities	Not reported	No source recorded
2008-12-31	Current assets / current liabilities	Not reported	No source recorded
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
2010-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 573,042 Exact value Exact value: -573042 USD 2001-01-01 – 2001-12-31: -573042 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2001-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -573042 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -573042 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000891020-03-001028.txt#6990 The citation records this snapshot. The page link may show a newer release later.	USD 685,018 Exact value Exact value: 685018 USD 2001-01-01 – 2001-12-31: 685018 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2001-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: 685018 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 685018 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000891020-03-001028.txt#7278 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2002-01-01 – 2002-12-31	−USD 2.66 million Exact value Exact value: -2661152 USD 2002-01-01 – 2002-12-31: -2661152 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2002-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -2661152 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2661152 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000891020-04-000342.txt#5964 The citation records this snapshot. The page link may show a newer release later.	−USD 960,207 Exact value Exact value: -960207 USD 2002-01-01 – 2002-12-31: -960207 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2002-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: -960207 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -960207 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000891020-03-001028.txt#7278 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 8.74 million Exact value Exact value: -8742537 USD 2003-01-01 – 2003-12-31: -8742537 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2003-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -8742537 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8742537 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-06-061898.txt#3415 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2004 2004-01-01 – 2004-12-31	−USD 5.75 million Exact value Exact value: -5747681 USD 2004-01-01 – 2004-12-31: -5747681 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2004-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -5747681 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5747681 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-07-053283.txt#3491 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2005 2005-01-01 – 2005-12-31	−USD 8.89 million Exact value Exact value: -8886063 USD 2005-01-01 – 2005-12-31: -8886063 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2005-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -8886063 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8886063 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000934936-08-000015.txt#7039 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2006 2006-01-01 – 2006-12-31	−USD 10.74 million Exact value Exact value: -10743230 USD 2006-01-01 – 2006-12-31: -10743230 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2006-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -10743230 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10743230 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000934936-08-000015.txt#7039 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2007 2007-01-01 – 2007-12-31	−USD 10.62 million Exact value Exact value: -10618938 USD 2007-01-01 – 2007-12-31: -10618938 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2007-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -10618938 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10618938 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000934936-09-000012.txt#7911 The citation records this snapshot. The page link may show a newer release later.	−USD 7.76 million Exact value Exact value: -7758021 USD 2007-01-01 – 2007-12-31: -7758021 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2007-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: -7758021 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7758021 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0000934936-09-000012.txt#8203 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 6.14 million Exact value Exact value: -6140000 USD 2008-01-01 – 2008-12-31: -6140000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2008-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -6140000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6140000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-10-065742.txt#3454 The citation records this snapshot. The page link may show a newer release later.	−USD 4.73 million Exact value Exact value: -4727000 USD 2008-01-01 – 2008-12-31: -4727000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2008-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: -4727000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4727000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-10-065742.txt#3574 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2009-01-01 – 2009-12-31	−USD 6.87 million Exact value Exact value: -6869000 USD 2009-01-01 – 2009-12-31: -6869000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2009-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -6869000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6869000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5378 The citation records this snapshot. The page link may show a newer release later.	−USD 5 million Exact value Exact value: -5002000 USD 2009-01-01 – 2009-12-31: -5002000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2009-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: -5002000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5002000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5538 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2010-01-01 – 2010-12-31	−USD 3.21 million Exact value Exact value: -3205000 USD 2010-01-01 – 2010-12-31: -3205000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCOLR Pharma, Inc. · 2010-12-31 SCOLR Pharma, Inc. (edgar:934936) Net Income: -3205000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3205000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5378 The citation records this snapshot. The page link may show a newer release later.	−USD 2.96 million Exact value Exact value: -2957000 USD 2010-01-01 – 2010-12-31: -2957000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCOLR Pharma, Inc. · 2010-12-31 SCOLR Pharma, Inc. (edgar:934936) Operating Cash Flow: -2957000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T17:53:49Z Snapshot: 696538daa180f9e434ac0b0285d58c5277e3e41bcf642426f9e705404cfb3dcd Dimensions: Consolidated View: https://fundies.io/companies/edgar/934936/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2957000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/934936/0001193125-11-081479.txt#5538 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

61 filings · 218 latest values · 218 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000934936, 934936, edgar:934936

Also known as NUTRACEUTIX INC, SCOLR INC, SCOLR Pharma, Inc.

SCOLR Pharma, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation